Clinical Trial Update: A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SSGJ-709 in patients with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SSGJ-709

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: RECRUITING